Migraine study measuring CGRP levels by age and sex
Part of Brain & nervous system, Pain clinical trials.
This study measures a substance called CGRP in saliva from people with migraine and healthy volunteers to see how it changes with age and sex. It may help researchers understand migraine better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with migraine by a doctor using ICHD-3 criteria
- You are a healthy volunteer without headaches and no close family with headaches
- You do not have a serious medical or nerve-related illness
- You do not have any problem with your salivary glands
- You have not abused tobacco, alcohol, or drugs in the last year
- You are not currently taking daily medicine to prevent migraines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a substance called CGRP (a protein linked to migraines) can safely trigger a migraine with aura in people who already have this condition. You'll receive an infusion and be monitored to see how your body responds.
This study looks at blood samples from people with migraine to find proteins and other markers that might explain why migraines happen. The goal is to better understand migraine, which could help find better treatments in the future.
This study looks at tears to find markers that may help diagnose migraine and understand it better. If you have migraine, you may also receive a new class of migraine treatment (anti-CGRP antibodies or gepants) if your doctor recommends it.
This study looks at how sensitive people with migraine are to pressure and pain, and how this affects their headache burden and quality of life. It compares two ways of measuring pain sensitivity to better understand migraine.
This study looks at how migraine may start or affect children by comparing young people who either have migraine symptoms or are at higher risk. It may help researchers understand migraine patterns and who could benefit from early prevention.
This study tests a CGRP-blocking antibody to see how it affects migraine symptoms and the body’s automatic (involuntary) nerve functions. It may help people with migraine who have already tried several preventive medicines.
Hear when a new Migraine Headache trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.